| Human Disease |
Spinal and Bulbar Muscular Atrophy, X-Linked 1; SMAX1 OMIM ID: 313200 |
|||||||||||||||||||||
| Synonyms | Bulbospinal Muscular Atrophy, X-Linked; Bulbospinal Neuronopathy, X-Linked Recessive; XBSN; Kennedy Disease; KD; Kennedy Spinal and Bulbar Muscular Atrophy; Spinal and Bulbar Muscular Atrophy; SBMA | |||||||||||||||||||||
| View all models | View ALL (7) mouse models for this human disease. | |||||||||||||||||||||
|
Genes and mouse models |
Mutations in human and/or mouse homologs are associated with this disease
|
|||||||||||||||||||||
|
Transgenes and other genome features |
Transgenes and other genome features developed in mice to model this disease.
|
|||||||||||||||||||||
| Allelic Composition | Genetic Background | Reference | Phenotypes |
| Artm4(AR)Dmr/Y |
involves: 129S1/Sv * C57BL/6J | J:104360, J:114552 | View |
| Allelic Composition | Genetic Background | Reference | Phenotypes |
| Tg(ACTA1-Ar)141Kyjo/0 |
involves: C4 * C57BL/6J | J:127205 | View |
| Allelic Composition | Genetic Background | Reference | Phenotypes |
| Tg(AR*100Q)#Als/0 |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J | J:170487 | View |
| Allelic Composition | Genetic Background | Reference | Phenotypes |
| Tg(AR*100Q)C25Als/0 |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J | J:89772 | View |
| Allelic Composition | Genetic Background | Reference | Phenotypes |
| Tg(AR*100Q)C32Als/0 |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J | J:89772 | View |
| Allelic Composition | Genetic Background | Reference | Phenotypes |
| Tg(CAG-AR*97Q)7-8Sobu/? |
involves: C57BL/6 * C57BL/6J * DBA/2 | J:128519 | View |
| Allelic Composition | Genetic Background | Reference | Phenotypes |
| Tg(Prnp-AR*112Q)#Deme/0 |
involves: C57BL/6 * SJL | J:134789 | View |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc |
||
|
Citing These Resources Funding Information Warranty Disclaimer & Copyright Notice Send questions and comments to User Support. |
last database update 05/08/2013 MGI 5.13 |
|
|
|
||